Articles & Presentations
IMS works with a variety of media outlets and trade associations to share expertise on issues impacting the pharmaceutical industry. This section provides abstracts and PDFs of current published articles, as well as extracts from recent industry presentations.
The Future of the Blockbuster Model
IMS Consultants examine the blockbuster model and the implications of this model on such areas as pharmacogenomics.
Nov 21, 2003
The U.S. Diabetes Market: A Special Report from IMS
IMS has prepared an in-depth analysis of the U.S. diabetes market, where Type 2 diabetes is reaching epidemic proportions.
Nov 4, 2003
IMS Health Analyzes Testosterone Use in the U.S.
Much has been written in the news lately about the declining market for hormone replacement therapy for females. The testosterone replacement therapy (TRT) market, whose patients are mostly male, however, is experiencing strong growth.
Oct 13, 2003
Detailing Gets Personal
As pharma sales forces grow and their productivity declines, the question on everyone's mind is, "Has the traditional detail lost its punch?" The answer is unequivocally no. The sales force is still the best medium for forging valued and trusted relationships with targeted physicians. Integrated segmentation may be pharma's key to "repersonalizing" the selling process, according to IMS Consulting's Ron Brand and Pankaj Kumar.
Aug 18, 2003
IMS Session at BIO 2003 to Feature Leading Biotech CEOs
IMS Health will sponsor a session titled, “Biotechnology: Coming of Age,” at the industry’s largest biotechnology event June 23 in Washington, D.C.
Jun 20, 2003
IMS Review: Steady but Not Stellar
Despite a sluggish economy, slowdown in drug approvals and decline in blockbusters, the U.S. pharma industry posted respectable gains last year. The U.S. still leads the world in solid growth and accounts for more than half of the world market. IMS Consulting's Pankaj Kumar and Ana-Maria Zaugg, VP, Corporate Strategic Planning, review 2002 trends and encouraging signs for 2003.
May 8, 2003
e-Marketing at the Point of Prescription
In recent years, there has been a marked increase in "e-Marketing" in the U.S. pharmaceutical industry.
Jan 29, 2003
Spending Hits A Wall
Pharma companies invested $12 billion in promoting to physicians and consumers in 2001, but after the highs of 2000, spending in 2001 seemed stunted - a growth rate of 9 versus 13 percent.
Nov 25, 2002
Presentation: Nov. 13 SG Cowen Health Care Investor Conference
Gilles Pajot, executive vice president and president, IMS European Region, presented IMS’ global pharmaceutical outlook to investors and analysts attending the SG Cowen Global Health Care Conference in Paris, France.
Nov 13, 2002
Presentation: Oct. 30 Salomon Smith Barney Investor Conference
Gary Noon, president, IMS U.S., gave a presentation highlighting IMS’ global pharmaceutical outlook to investors and analysts attending the Salomon Smith Barney 2002 Health Care Conference in New York.
Oct 31, 2002
|
| 
more
